Industry news: Aurora, Dilon, Siemens

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Aurora Breast MRI of Orange County has made its dedicated breast MRI service available to patients throughout Orange County and Southern California for screening and early detection of breast cancer. Currently operating at the UC Irvine Manchester Pavilion in Orange, Aurora Breast MRI of Orange County will relocate to its permanent location within the UC Irvine Medical Center campus in Orange later this year. Aurora uses MRI technology to detect breast cancer. The system provides an entire 3D composite model of the breast.

Dilon Technologies, a U.S.-based medical device manufacturer of a high-resolution, small field-of-view gamma cameras, in Q4 2006 tripled its prior year's camera orders. The company also made gains in Europe, Canada and Korea. The Dilon 6800 Gamma Camera, optimized for breast-specific gamma imaging (BSGI), is designed to be a valuable diagnostic tool when mammography is inconclusive.
Radiologist Ted Fogarty, MD, of Medcenter One Hospital of Bismarck, N.D. said, "Medcenter One purchased the Dilon 6800 Gamma Camera to effectively deal with the limitations in mammography. Mammograms can be so hindered by dense breast tissue that this condition can significantly decrease the effectiveness of finding cancer with mammography alone. BSGI is an ideal diagnostic complement to mammography. Paired, these two imaging modalities significantly increase the likelihood of catching cancers in their earliest and most treatable stages."

Siemens Medical Solutions Diagnostics showcased its portfolio of diagnostic solutions for the first time at the annual Clinical Laboratory Managers Association Conference and Exhibition in Houston, Texas.

Siemens Medical Solutions Diagnostics entered the in-vitro diagnostics market when Siemens Medical Solutions acquired Diagnostic Products Corporation. Siemens Medical Solutions Diagnostics has an extensive portfolio of diagnostic analyzers for assessing and managing health in a myriad of disease states, including cardiovascular, kidney and infectious diseases, HIV, oncology, diabetes and virology. Key business areas include: laboratory testing and laboratory automation, enhancing the ability to detect, monitor and manage disease as well as point-of-care systems for urinalysis, blood gas and diabetes testing.